Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

DNLI

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-01-06Shares Purchased (TTM):0Shares Sold (TTM):52,416

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:135,657,919Shares Outstanding:186,636,978Institutional Ownership Pct.:72.69%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Nonrelated Party	-	-	-	-	-	-	-	-	-	-	-	-7
Related Party	-	-	-	-	-	-	-	-	-	-	-	-7
Assets Current
Cash And Cash Equivalents At Carrying Value	202	388	205	91	141	57	175	91	75	61	127	148
Marketable Securities Current	509	600	663	757	758	761	657	746	821	876	907	961
Prepaid Expense And Other Assets Current	35	35	33	34	36	61	32	32	32	37	30	34
Assets Current	754	1,023	901	883	935	879	864	869	928	974	1,064	1,143
Marketable Securities Noncurrent	230	64	98	25	78	236	359	445	451	491	0	8
Property Plant And Equipment Net	50	52	52	54	59	58	55	51	48	47	46	48
Finance Lease Right Of Use Asset	-	48	49	49	50	50	48	39	-	-	0	-
Operating Lease Right Of Use Asset	17	18	19	20	21	22	23	24	25	25	26	27
Intangible Assets Net Excluding Goodwill	35	36	-	-	-	-	-	-	-	-	-	-
Other Assets Noncurrent	26	26	26	25	23	27	25	26	51	45	18	11
Assets	1,158	1,266	1,145	1,056	1,166	1,271	1,374	1,454	1,503	1,581	1,154	1,237
Liabilities And Stockhold…
Other Liabilities Current	-	-	-	-	-	-	-	-	-	-	0	-
Liabilities Current
Employee Related Liabilities Current	-	9	-	18	12	8	-	15	10	8	-	16
Accounts Payable Current	12	40	3	7	11	8	11	10	14	12	9	-
Accrued Liabilities Current	78	70	95	5	7	7	91	5	6	6	68	-
Contract With Customer Liability Current	-	-	-	-	-	-	-	-	-	-	0	-
Liabilities Current	90	110	98	90	91	92	102	87	75	83	78	71
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	-
Operating Lease Liability Noncurrent	22	25	27	30	32	34	37	39	41	43	45	47
Operating Lease Liability Current	-	10	-	9	9	9	-	8	8	8	-	7
Finance Lease Liability Noncurrent	-	6	6	6	6	6	6	6	-	-	0	-
Other Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities	323	340	131	129	139	149	144	136	116	126	123	118
Stockholders Equity
Preferred Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Value	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Value Outstanding	2	2	2	2	2	2	2	2	2	2	2	-
Additional Paid In Capital	3,143	3,105	3,063	2,846	2,820	2,791	2,765	2,735	2,705	2,673	2,145	2,114
Common Stock Value	-	-	-	-	-	-	-	-	-	-	2	2
Accumulated Other Comprehensive Income Loss Net Of…	-2	-1	1	1	1	2	2	6	-3	-1	1	-1
Retained Earnings Accumulated Deficit	-2,308	-2,180	-2,052	-1,923	-1,796	-1,672	-1,539	-1,424	-1,317	-1,218	-1,116	-997
Stockholders Equity	835	926	1,014	926	1,027	1,123	1,230	1,318	1,387	1,455	1,031	1,118
Liabilities And Stockholders Equity	1,158	1,266	1,145	1,056	1,166	1,271	1,374	1,454	1,503	1,581	1,154	1,237
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	40	40	40	40	40	40	40	40	40	40	40	40
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	400	400	400	400	400	400	400	400	400	400	400	400
Common Stock Shares Issued	160	159	156	147	146	145	144	144	143	143	138	138
Shares Outstanding	160	159	156	147	146	145	144	144	143	143	138	138

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	6.75%	29.73%	17.25%	-	-	-	-	-	-	-	-	-
2025	-5.23%	0.93%	-2.15%	10.85%	10.78%	16.95%	35.11%	17.07%	40.53%	-5.84%	-3.97%	-13.07%
2024	10.15%	37.80%	43.03%	6.17%	32.49%	18.26%	-15.40%	-30.25%	-24.81%	-22.42%	-31.51%	-25.91%
2023	-	-	-	-9.76%	-20.13%	-29.54%	-10.65%	1.08%	-20.54%	-2.92%	-20.83%	1.48%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.37	9.28	9.16	9.79	10.27	9.56	8.46	9.98	12.46	11.79	13.65	16.06
Quick Ratio	7.98	8.97	8.82	9.41	9.87	8.90	8.14	9.61	12.02	11.34	13.27	15.58
Working Capital	663.84M	912.60M	802.31M	792.45M	843.65M	786.76M	762.23M	781.75M	853.85M	890.99M	986.16M	1.07B
Leverage & Debt
Debt to Equity	0.39	0.37	0.13	0.14	0.14	0.13	0.12	0.10	0.08	0.09	0.12	0.11
Debt Ratio	0.28	0.27	0.11	0.12	0.12	0.12	0.11	0.09	0.08	0.08	0.11	0.10
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20	0.25	0.27
Per Share Metrics
Diluted EPS TTM	-2.73	-2.72	-2.97	-2.89	-2.79	-2.65	-2.57	-2.52	-2.49	-0.92	-1.06	-0.90
Free Cash Flow Per Share TTM	-2.38	-2.27	-2.47	-1.62	-1.36	-2.24	-2.21	-2.22	-2.38	-2.85	-2.70	-2.52
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-37,938.04%	-65.54%	-59.51%	-50.23%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-33,121.86%	-46.46%	-43.94%	-36.88%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-99.63%	201.22%	214.60%	204.83%
Net Income Growth (1Y)	6.77%	11.91%	21.23%	16.67%	14.15%	230.75%	191.12%	243.56%	226.90%	-62.96%	-55.45%	-58.88%
EPS Growth (1Y)	-2.28%	2.67%	15.49%	14.66%	12.41%	188.61%	143.15%	179.07%	165.36%	-66.15%	-59.29%	-63.11%
Valuation Metrics
P/E TTM	-9.42	-7.05	-5.56	-5.02	-5.01	-5.13	-7.93	-11.55	-9.34	-22.34	-20.30	-22.82
P/B TTM	5.77	3.87	2.81	2.70	2.34	2.07	2.73	3.74	2.83	2.11	2.86	2.54
P/S TTM	-	-	-	-	-	-	-	-	3,094.13	10.38	8.92	8.42
Market Cap	4.82B	3.58B	2.85B	2.50B	2.40B	2.33B	3.35B	4.94B	3.92B	3.07B	2.95B	2.84B
Enterprise Value	4.61B	3.20B	2.65B	2.42B	2.26B	2.27B	3.18B	4.85B	3.84B	3.00B	2.82B	2.69B
Calculated Values
Free Cash Flow TTM	-446.41M	-423.58M	-426.46M	-278.66M	-233.01M	-384.38M	-363.61M	-375.69M	-402.10M	-425.11M	-370.93M	-347.55M
Net Debt	-204.64M	-385.22M	-202.90M	-88.52M	-138.74M	-54.46M	-170.92M	-86.58M	-76.25M	-62.15M	-128.68M	-149.59M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-01-06Sale

Owner: Watts, Ryan J.

Title: President and CEO

Shares: 35,198

Price/Share: $16.50

Value: $580,767.00

Shares Owned: 296,833

Relationship: Director,Officer

Ownership: Direct

2026-01-06Sale

Owner: Schuth, Alexander O.

Title: COFO and Secretary

Shares: 17,218

Price/Share: $16.50

Value: $284,097.00

Shares Owned: 282,828

Relationship: Officer

Ownership: Direct

2025-08-13Sale

Owner: Ho, Carole

Title: Chief Medical Officer

Shares: 806

Price/Share: $14.64

Value: $11,799.84

Shares Owned: 216,585

Relationship: Officer

Ownership: Direct

2025-08-12Sale

Owner: Schuth, Alexander O.

Title: COFO and Secretary

Shares: 2,937

Price/Share: $13.58

Value: $39,884.46

Shares Owned: 242,346

Relationship: Officer

Ownership: Direct

2025-07-09Sale

Owner: Watts, Ryan J.

Title: President and CEO

Shares: 495,282

Price/Share: $15.00

Value: $7,429,230.00

Shares Owned: 253,071

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-01-06	Watts, Ryan J.	Director,Officer	President and CEO	Direct	Sale	35,198	16.50	$580,767.00	296,833	4
2026-01-06	Schuth, Alexander O.	Officer	COFO and Secretary	Direct	Sale	17,218	16.50	$284,097.00	282,828	4
2025-08-13	Ho, Carole	Officer	Chief Medical Officer	Direct	Sale	806	14.64	$11,799.84	216,585	4
2025-08-12	Schuth, Alexander O.	Officer	COFO and Secretary	Direct	Sale	2,937	13.58	$39,884.46	242,346	4
2025-07-09	Watts, Ryan J.	Director,Officer	President and CEO	Direct	Sale	495,282	15.00	$7,429,230.00	253,071	4
2025-01-07	Ho, Carole	Officer	Chief Medical Officer	Direct	Sale	2,907	20.81	$60,494.67	175,673	4
2025-01-07	Krognes, Steve E.	Director	-	Direct	Sale	3,339	20.81	$69,484.59	25,757	4
2025-01-07	Watts, Ryan J.	Director,Officer	President and CEO	Direct	Sale	7,650	20.81	$159,196.50	253,071	4
2025-01-07	Schuth, Alexander O.	Officer	COFO and Secretary	Direct	Sale	2,907	20.81	$60,494.67	244,308	4
2025-01-02	Sato, Vicki L	Director	-	Direct	Sale	3,080	20.91	$64,402.80	107,976	4
2024-12-31	Krognes, Steve E.	Director	-	Direct	Sale	30,000	20.25	$607,500.00	29,096	4
2024-11-11	Schenkein, David P	Director	-	Direct	Sale	59,441	32.48	$1,930,643.68	9,220	4
2024-11-07	Sato, Vicki L	Director	-	Direct	Sale	1,020	30.00	$30,600.00	111,056	4
2024-11-07	Schuth, Alexander O.	Officer	COFO and Secretary	Direct	Sale	15,558	30.56	$475,452.48	178,066	4
2024-11-01	Sato, Vicki L	Director	-	Direct	Sale	3,080	27.07	$83,375.60	112,076	4
2024-10-18	Watts, Ryan J.	Director,Officer	President and CEO	Direct	Sale	40,000	27.69	$1,107,600.00	235,807	4
2024-09-30	Krognes, Steve E.	Director	-	Direct	Sale	30,000	29.03	$870,900.00	29,096	4
2024-09-13	Sato, Vicki L	Director	-	Direct	Sale	1,020	30.00	$30,600.00	115,156	4
2024-09-03	Sato, Vicki L	Director	-	Direct	Sale	3,080	25.18	$77,554.40	116,176	4
2024-08-21	Ho, Carole	Officer	Chief Medical Officer	Direct	Sale	20,005	24.68	$493,723.40	118,810	4
2024-08-21	Schuth, Alexander O.	Officer	COFO and Secretary	Direct	Sale	2,547	24.78	$63,114.66	178,066	4
2024-08-20	Krognes, Steve E.	Director	-	Direct	Sale	1,727	23.79	$41,085.33	32,677	4
2024-08-20	Watts, Ryan J.	Director,Officer	President and CEO	Direct	Sale	2,260	23.79	$53,765.40	235,807	4
2024-08-13	Schuth, Alexander O.	Officer	COFO and Secretary	Direct	Sale	2,272	22.89	$52,006.08	186,419	4
2024-08-13	Ho, Carole	Officer	Chief Medical Officer	Direct	Sale	2,337	22.89	$53,493.93	141,268	4
2024-07-01	Krognes, Steve E.	Director	-	Direct	Sale	30,000	22.46	$673,800.00	34,404	4
2024-07-01	Sato, Vicki L	Director	-	Direct	Sale	3,080	22.49	$69,269.20	119,256	4
2024-06-06	Cook, Jennifer E.	Director	-	Direct	Sale	1,458	21.73	$31,682.34	20,038	4
2024-05-15	Sato, Vicki L	Director	-	Direct	Sale	1,674	20.39	$34,132.86	116,369	4
2024-04-15	Sato, Vicki L	Director	-	Direct	Sale	1,666	18.29	$30,471.14	118,043	4
2024-04-01	Krognes, Steve E.	Director	-	Direct	Sale	92,500	20.50	$1,896,250.00	47,341	4
2024-03-15	Sato, Vicki L	Director	-	Direct	Sale	1,666	20.10	$33,486.60	119,709	4
2024-02-15	Sato, Vicki L	Director	-	Direct	Sale	1,666	18.37	$30,604.42	121,375	4
2024-02-14	Schuth, Alexander O.	Officer	COFO and Secretary	Direct	Sale	20,128	17.66	$355,460.48	187,341	4
2024-02-14	Ho, Carole	Officer	Chief Medical Officer	Direct	Sale	1,405	17.79	$24,994.95	143,605	4
2024-02-13	Krognes, Steve E.	Director	-	Direct	Sale	2,750	17.29	$47,547.50	139,841	4
2024-02-13	Watts, Ryan J.	Director,Officer	President and CEO	Direct	Sale	9,589	17.29	$165,793.81	238,067	4
2024-01-16	Sato, Vicki L	Director	-	Direct	Sale	1,666	18.42	$30,687.72	123,041	4
2024-01-10	Ho, Carole	Officer	Chief Medical Officer	Direct	Sale	4,668	19.02	$88,785.36	147,794	4
2024-01-09	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	7,818	19.78	$154,640.04	2,268,363	4
2024-01-05	Krognes, Steve E.	Director	-	Direct	Sale	3,208	19.43	$62,331.44	142,591	4
2024-01-05	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	17,483	19.43	$339,694.69	2,276,181	4
2024-01-05	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	9,972	19.43	$193,755.96	198,777	4
2024-01-05	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	9,972	19.43	$193,755.96	539,307	4
2023-12-15	Sato, Vicki L	Director	-	Direct	Sale	1,666	23.39	$38,967.74	124,707	4
2023-11-15	Sato, Vicki L	Director	-	Direct	Sale	1,666	19.13	$31,870.58	126,373	4
2023-10-16	Sato, Vicki L	Director	-	Direct	Sale	1,666	20.66	$34,419.56	128,039	4
2023-09-15	Sato, Vicki L	Director	-	Direct	Sale	1,666	23.98	$39,950.68	129,705	4
2023-08-23	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	2,522	23.17	$58,434.74	518,989	4
2023-08-23	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	2,522	23.22	$58,560.84	182,809	4
2023-08-21	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	2,478	22.59	$55,978.02	521,511	4
2023-08-21	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	2,478	22.60	$56,002.80	185,331	4
2023-08-21	Krognes, Steve E.	Director	-	Direct	Sale	1,419	22.60	$32,069.40	145,799	4
2023-08-21	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	2,309	22.59	$52,160.31	2,242,604	4
2023-08-15	Sato, Vicki L	Director	-	Direct	Sale	1,666	24.30	$40,483.80	131,371	4
2023-08-14	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	2,772	23.67	$65,613.24	518,989	4
2023-08-14	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	2,768	23.79	$65,850.72	182,809	4
2023-08-10	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	2,526	25.03	$63,225.78	2,239,913	4
2023-08-10	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	2,857	24.15	$68,996.55	185,577	4
2023-08-10	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	2,853	24.18	$68,985.54	521,761	4
2023-07-18	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	9,702	30.01	$291,157.02	518,989	4
2023-07-17	Sato, Vicki L	Director	-	Direct	Sale	1,666	29.60	$49,313.60	133,037	4
2023-06-28	Sato, Vicki L	Director	-	Direct	Sale	1,666	29.76	$49,580.16	134,703	4
2023-06-16	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	50,000	31.40	$1,570,000.00	2,239,913	4
2023-05-15	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	10,000	28.89	$288,900.00	528,691	4
2023-04-21	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	24,800	25.15	$623,720.00	2,239,913	4
2023-04-13	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	4,898	25.04	$122,645.92	528,691	4
2023-02-15	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	1,476	29.40	$43,394.40	182,809	4
2023-02-13	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	2,548	30.10	$76,694.80	184,285	4
2023-02-13	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	33,815	30.08	$1,017,155.20	2,239,913	4
2023-02-13	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	3,497	30.09	$105,224.73	528,691	4
2023-02-13	Krognes, Steve E.	Director	-	Direct	Sale	2,119	30.10	$63,781.90	143,002	4
2023-02-10	Watts, Ryan J.	Director,Officer	President and CEO	Indirect	Sale	25,000	29.10	$727,500.00	2,229,031	4
2023-02-08	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	1,521	30.88	$46,968.48	180,183	4
2023-02-08	Krognes, Steve E.	Director	-	Direct	Sale	1,377	30.88	$42,521.76	145,121	4
2023-02-08	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	1,521	30.89	$46,983.69	499,902	4
2023-01-17	Schuth, Alexander O.	Officer	COFO and Secretary	Indirect	Sale	10,000	29.70	$297,000.00	497,173	4
2023-01-09	Ho, Carole	Officer	Chief Medical Officer	Indirect	Sale	1,459	28.48	$41,552.32	177,454	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

72.69%

Inst. Shares: 135,657,919

Shares Outstanding: 186,636,978

2025-12-31

80.43%

Inst. Shares: 138,866,702

Shares Outstanding: 172,649,097

2025-09-30

72.27%

Inst. Shares: 124,605,703

Shares Outstanding: 172,421,492

2025-06-30

73.91%

Inst. Shares: 126,722,791

Shares Outstanding: 171,449,847

2025-03-31

74.54%

Inst. Shares: 127,630,896

Shares Outstanding: 171,222,030

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	135,657,919	186,636,978	72.69%
2025-12-31	138,866,702	172,649,097	80.43%
2025-09-30	124,605,703	172,421,492	72.27%
2025-06-30	126,722,791	171,449,847	73.91%
2025-03-31	127,630,896	171,222,030	74.54%
2024-12-31	121,625,227	164,473,772	73.95%
2024-09-30	120,437,018	169,456,988	71.07%
2024-06-30	114,398,378	168,831,329	67.76%
2024-03-31	111,532,167	149,404,188	74.65%
2023-12-31	104,878,042	137,370,897	76.35%
2023-09-30	101,052,665	137,644,534	73.42%
2023-06-30	100,068,995	137,047,227	73.02%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Denali Therapeutics Inc. (DNLI) — SEC Financial Statements & Analysis

Denali Therapeutics Inc. (DNLI) is a biological products, (no diagnostic substances) company, incorporated in DE. Denali Therapeutics Inc. trades on Nasdaq as: DNLI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Denali Therapeutics Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.39x, a Price-to-Sales (P/S) ratio of 3094.13x (TTM), a Price-to-Book (P/B) ratio of 5.77x (TTM), at a market cap of $4.82B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.39x
P/S TTM: 3094.13x
P/B TTM: 5.77x
Market Cap: $4.82B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Denali Therapeutics Inc. in?

Denali Therapeutics Inc. (DNLI) operates in the Biological Products, (No Diagnostic Substances) industry.

What is DNLI's market cap?

Denali Therapeutics Inc. (DNLI) has a market capitalization of $4.82B as of 2026-06-30.

What exchange does DNLI trade on?

Denali Therapeutics Inc. (DNLI) trades on the Nasdaq.

Where is Denali Therapeutics Inc. incorporated?

Denali Therapeutics Inc. is incorporated in DE.